These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16792143

  • 1. Sarcoidosis-related hypercalcemia in 3 chronic hemodialysis patients.
    Huart A, Kamar N, Lanau JM, Dahmani A, Durand D, Rostaing L.
    Clin Nephrol; 2006 Jun; 65(6):449-52. PubMed ID: 16792143
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [Recurrence of sarcoidosis in a hemodialysis patient confirmed by abnormal calcium metabolism].
    Tanaka K, Tanimoto H, Sakai K, Arai K, Mizuiri S, Hasegawa A, Otsuka T, Uchino M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():83-5; discussion 86. PubMed ID: 16272637
    [Abstract] [Full Text] [Related]

  • 4. [Hypercalcemia in a female patient with chronic kidney failure secondary to sarcoidosis: a metabolic study of the calcium metabolism and bone histology].
    Caravaca F, Cubero JJ, de Francisco AL, Arrobas M, Pizarro JL, Sánchez-Casado E.
    Med Clin (Barc); 1991 May 04; 96(17):659-61. PubMed ID: 2056801
    [Abstract] [Full Text] [Related]

  • 5. [Sarcoidosis and hypercalcemia in a patient undergoing hemodialysis].
    Kuwae N, Oshiro Y, Nakazato S.
    Nihon Jinzo Gakkai Shi; 2003 May 04; 45(2):98-103. PubMed ID: 12703405
    [Abstract] [Full Text] [Related]

  • 6. [Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options].
    Ackermann D.
    Ther Umsch; 2007 May 04; 64(5):281-6. PubMed ID: 17685088
    [Abstract] [Full Text] [Related]

  • 7. Sarcoidosis in a chronic dialysis patient diagnosed by sarcoidosis-related hypercalcemia with no common systemic clinical manifestations: a case report and review of the literature.
    Arai Y, Tanaka H, Hirasawa S, Aki S, Inaba N, Aoyagi M, Tsuura Y, Tamura T.
    Intern Med; 2013 May 04; 52(23):2639-44. PubMed ID: 24292755
    [Abstract] [Full Text] [Related]

  • 8. Hypercalcemia and renal failure in the course of sarcoidosis--case report.
    Kempisty A, Kuś J.
    Pneumonol Alergol Pol; 2012 May 04; 80(6):570-5. PubMed ID: 23109211
    [Abstract] [Full Text] [Related]

  • 9. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
    Dahmani O, Sophoclis C, Kebir M, Bouguern D, Sakho A, Demarchi P.
    Saudi J Kidney Dis Transpl; 2017 May 04; 28(1):154-157. PubMed ID: 28098117
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis.
    Barré PE, Gascon-Barré M, Meakins JL, Goltzman D.
    Am J Med; 1987 Jun 04; 82(6):1259-62. PubMed ID: 3605143
    [Abstract] [Full Text] [Related]

  • 11. Coexisting primary hyperparathyroidism and sarcoidosis in a patient with severe hypercalcemia.
    Yoshida T, Iwasaki Y, Kagawa T, Sasaoka A, Horino T, Morita T, Hashimoto K.
    Endocr J; 2008 May 04; 55(2):391-5. PubMed ID: 18385529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Cortico-dependent hypercalcemia in 3 patients on chronic hemodialysis].
    Fuss M, Van Herweghem JL, Bergman P, Verbeelen D.
    J Urol Nephrol (Paris); 1978 May 04; 84(4-5):318-23. PubMed ID: 682232
    [No Abstract] [Full Text] [Related]

  • 14. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S, Lafrance JP, Pichette V, Bell RZ, Desforges K, Lepage L, Ouellet G, Ouimet D, Leblanc M, Lamarche C, Bezzaoucha S, Vallee M.
    Int Urol Nephrol; 2017 Feb 04; 49(2):325-328. PubMed ID: 27822674
    [Abstract] [Full Text] [Related]

  • 15. Calcitriol-mediated hypercalcemia: causes and course in 101 patients.
    Donovan PJ, Sundac L, Pretorius CJ, d'Emden MC, McLeod DS.
    J Clin Endocrinol Metab; 2013 Oct 04; 98(10):4023-9. PubMed ID: 23979953
    [Abstract] [Full Text] [Related]

  • 16. Hypercalcemia in two patients with sarcoidosis and Mycobacterium avium intracellulare not mediated by elevated vitamin D metabolites.
    Shrayyef MZ, DePapp Z, Cave WT, Wittlin SD.
    Am J Med Sci; 2011 Oct 04; 342(4):336-40. PubMed ID: 21760475
    [Abstract] [Full Text] [Related]

  • 17. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S, Kratzsch J, Paschke R, Koch CA.
    Med Sci Monit; 2007 Nov 04; 13(11):CS133-136. PubMed ID: 17968303
    [Abstract] [Full Text] [Related]

  • 18. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
    Gkonos PJ, London R, Hendler ED.
    N Engl J Med; 1984 Dec 27; 311(26):1683-5. PubMed ID: 6548798
    [No Abstract] [Full Text] [Related]

  • 19. Hypercalcemia with renal failure.
    Bhavani N, Praveen VP, Jayakumar RV, Nair V, Muraleedharan M, Kuma H, Unnikrishnan AG, Menon VU.
    J Assoc Physicians India; 2012 Jun 27; 60():52-4. PubMed ID: 23409426
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.